Matches in Nanopublications for { ?s ?p "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_assertion description "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_provenance.
- NP804708.RA29EMDHzP9Ypljirz9N2JFrNAR8dJ28cxUKL_Gy1hl4U130_assertion description "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804708.RA29EMDHzP9Ypljirz9N2JFrNAR8dJ28cxUKL_Gy1hl4U130_provenance.
- NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_assertion description "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_provenance.
- NP804713.RAxbZTsx4u9fSUzuqQEghk5P_9bsgjbbUpK0pbOqp08Bk130_assertion description "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804713.RAxbZTsx4u9fSUzuqQEghk5P_9bsgjbbUpK0pbOqp08Bk130_provenance.
- NP1116203.RAENflzHzMo-SBm4aDjdSh2IXmeAhYxUXKdm3Gn-jaQrY130_assertion description "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116203.RAENflzHzMo-SBm4aDjdSh2IXmeAhYxUXKdm3Gn-jaQrY130_provenance.
- NP1116202.RA_svQEla7WJA32S7HqKCdgbkRtbnivIlteEhkStq0NGA130_assertion description "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116202.RA_svQEla7WJA32S7HqKCdgbkRtbnivIlteEhkStq0NGA130_provenance.